With excellent selectivity against human DUBs, deSUMOylases, deneddylases, and unrelated proteases, ML323 boosts cytotoxicity in cisplatin-resistant NSCLC by blocking PCNA and FANCD2 deubiquitination [38, 264]. This evidence concerns the gene FANCD2 and non-small cell lung carcinoma.